Chiropractic and Self-care for Back-Related Leg Pain
Recruitment status was Active, not recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The primary aims of the project are to determine the clinical efficacy of chiropractic Spinal Manipulative Therapy (SMT) plus self-care education versus self-care education alone in 192 patients with sub-acute and chronic Back Related Leg Pain (BRLP) in both the short-term (after 12 weeks) and long-term (after 52 weeks). The primary outcome variable is leg pain and secondary outcome variables include low back pain, disability, bothersomeness and frequency of symptoms, general health status, and fear avoidance behavior.
Secondary aims are to describe and estimate between group differences in patient satisfaction, improvement, medication use, straight leg raise, torso endurance, and three biomechanical measures: continuous spinal motion, postural sway, and neuromuscular response to sudden load. Patient perceptions of treatment will also be assessed.
| Condition | Intervention |
|---|---|
|
Sub-acute and Chronic Back-related Leg Pain |
Other: Home exercise Other: Chiropractic Spinal Manipulative Therapy + Home exercise |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Chiropractic and Self-care for Back-Related Leg Pain |
- Patient-rated leg pain [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ] [ Designated as safety issue: No ]
- Bothersomeness [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ] [ Designated as safety issue: No ]
- Frequency [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ] [ Designated as safety issue: No ]
- Disability [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ] [ Designated as safety issue: No ]
- General Health Status [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ] [ Designated as safety issue: No ]
- Fear Avoidance [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ] [ Designated as safety issue: No ]
- Patient Satisfaction [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ] [ Designated as safety issue: No ]
- Improvement [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ] [ Designated as safety issue: No ]
- Medication Use [ Time Frame: short-term = 12 weeks; long-term = 52 weeks ] [ Designated as safety issue: No ]
- Biomechanical test measures: Continuous lumbar motion, Standing postural sway, Neuromuscular response to a sudden load, Straight leg raise test, Torso muscle endurance [ Time Frame: short-term = 12 weeks ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 192 |
| Study Start Date: | June 2007 |
| Estimated Study Completion Date: | October 2010 |
| Estimated Primary Completion Date: | October 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1
Chiropractic Spinal Manipulative Therapy + Home exercise
|
Other: Chiropractic Spinal Manipulative Therapy + Home exercise
The number and frequency of treatments will be determined by the individual chiropractor, based on patient-rated symptoms, disability, palpation, and pain provocation tests. Up to 20 treatments will be provided over the 12 week treatment period, each treatment visit lasting from 10-20 minutes. Treatment will include manual spinal manipulation and mobilization.
|
|
Active Comparator: 2
Home exercise
|
Other: Home exercise
Patient education will be provided by trained therapists under the supervision of licensed chiropractic clinicians. Patients will attend four, 1 hour, one-on-one sessions.
|
Eligibility| Ages Eligible for Study: | 21 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Back-related leg pain > 3 on 0 to 10 scale.
- Sub-acute or chronic back-related leg pain defined as current episode > 4 weeks duration.
- Back-related leg pain classified as 2, 3, 4, or 6 using the Quebec Task Force (QTF) Classification system. This includes radiating pain into the proximal or distal part of the lower extremity, with or without neurological signs, with possible compression of a nerve root.
- 21 years of age and older.
- Stable prescription medication plan (no changes in prescription medications that affect musculoskeletal pain in the previous month).
Exclusion Criteria:
- Ongoing treatment for leg or low back pain by other health care providers.
- Progressive neurological deficits or cauda equina syndrome.
- QTF classifications 5 (spinal fracture) and 11 (other diagnoses including visceral diseases, compression fractures, metastases). These are serious conditions not amenable to the conservative treatments proposed.
- QTF 7 (spinal stenosis syndrome characterized by pain and/or paresthesias in one or both legs aggravated by walking).
- Uncontrolled hypertension or metabolic disease.
- Blood clotting disorders.
- Severe osteoporosis.
- Inflammatory or destructive tissue changes of the spine.
- Patients with surgical lumbar spine fusion or patients with multiple incidents of lumbar surgery. This is a subgroup of low back pain patients which generally have a poorer prognosis.
- Pregnant or nursing women.
- Current or pending litigation. Patients seeking financial compensation tend to respond differently to treatment.
Contacts and Locations| United States, Iowa | |
| Palmer Center for Chiropractic Research | |
| Davenport, Iowa, United States, 52803 | |
| United States, Minnesota | |
| Northwestern Health Sciences University | |
| Bloomington, Minnesota, United States, 55337 | |
| Principal Investigator: | Gert Bronfort, DC, PhD | Northwestern Health Sciences University |
More Information
No publications provided
| Responsible Party: | Gert Bronfort, DC, PhD, Northwestern Health Sciences University |
| ClinicalTrials.gov Identifier: | NCT00494065 History of Changes |
| Other Study ID Numbers: | R18HP07638, R18HP07638 |
| Study First Received: | June 27, 2007 |
| Last Updated: | February 11, 2010 |
| Health Authority: | United States: Institutional Review Board |
ClinicalTrials.gov processed this record on May 19, 2013